New type at Erciyes University (ERÜ) corona virusThe vaccine candidate developed against e (Covid-19) do-2 It was reported that the second dose of the study was started to be administered to the volunteers. According to the written statement made by the university, the second dose of the inactive vaccine candidate, whose phase-2 studies were continuing, was started to be given to the volunteers at the ERÜ Good Clinical Practice and Research Center (İKUM). In the…"Second dose started to be administered in phase-2 studies of local Covid-19 vaccine candidate – Health News"
According to the written statement made by the university, the first dose of the inactive vaccine candidate, whose phase-1 studies were started on November 5, 2020, within the scope of the phase-2 study, was given to the volunteers. ERÜ Vaccine Research and Development Application and Research Center (I ERAG) Covidien-19 against the developed and the Ministry of Health of Turkey Institutes of Health Administration (TÜSEB) the first dose of the scope of supported inactivated vaccine…"In phase-2 studies of the Covid-19 vaccine candidate at ERÜ, the first dose started to be administered to volunteers – Health News"